The Hospital Universitario de la Princesa is a hospital located in the Lista neighborhood in Madrid, Spain, part of the hospital network of the Servicio Madrileño de Salud. It is one of the healthcare institutions associated to the Autonomous University of Madrid for the purpose of clinical internship.

There are 564 beds in Hospital Universitario de la Princesa; Servicio de Hematologia.

During the past decade, Hospital Universitario de la Princesa; Servicio de Hematologia conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 5 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital Universitario de la Princesa; Servicio de Hematologia" #1 collaborator was "AbbVie" with 1 trials as a collaborator, "Biogen" with 1 trials as a collaborator, "Genentech, Inc." with 1 trials as a collaborator, "German CLL Study Group" with 1 trials as a collaborator and "Roche Pharma AG" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "Hospital Universitario de la Princesa; Servicio de Hematologia" are "Lymphocytic Leukemia, Chronic" (2 trials), "Non-Hodgkin's Lymphoma" (2 trials), "Chronic Lymphocytic Leukemia" (1 trials), "Multiple Myeloma" (1 trials) and "Myelodysplastic Syndromes" (1 trials). Many other conditions were trialed in "Hospital Universitario de la Princesa; Servicio de Hematologia" in a lesser frequency.

Most popular intervention types in "Hospital Universitario de la Princesa; Servicio de Hematologia" are "Drug" (7 trials). Other intervention types were less common.

The name of intervention was led by "Cyclophosphamide" (3 trials), "Obinutuzumab" (2 trials), "Bendamustine" (1 trials), "CC-5013" (1 trials) and "Chlorambucil" (1 trials). Other intervention names were less common.

The vast majority of trials in "Hospital Universitario de la Princesa; Servicio de Hematologia" are 7 trials for "All" genders.

Currently, there are NaN active trials in "Hospital Universitario de la Princesa; Servicio de Hematologia". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in Hospital Universitario de la Princesa; Servicio de Hematologia, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Hospital Universitario de la Princesa; Servicio de Hematologia, 1 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".